By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enlivex Therapeutics Ltd. 

POB 12167 Hadassah Ein Kerem

Jerusalem    91120  Israel
Phone: 972-2-6778753 Fax: 972-2-5722071


SEARCH JOBS


Industry
Biotechnology

Segment
Cell Therapy





Company News
Enlivex Therapeutics Ltd. Granted EU Orphan Drug Designation For Lead Product Apocell For Graft-Versus-Host Disease 1/26/2015 7:41:28 AM
Enlivex Therapeutics Ltd. Publishes Positive Results from Phase I/II Clinical Trial for the Treatment of Bone Marrow Transplant Recipients 11/4/2013 10:13:56 AM
Hadasit Bio Holdings Flagship Portfolio Company Enlivex Therapeutics Ltd. Awarded Orphan Drug Status for ApoCell, Inc. Treatment by the FDA 4/4/2013 10:18:21 AM
Enlivex Therapeutics Ltd. Announces Positive Results in Completion of Clinical Trial for the Treatment of Bone Marrow Transplant Recipients 10/25/2012 9:40:27 AM
Enlivex Therapeutics Ltd. Announces Positive Results in Completion of Clinical Trial for the Treatment of Bone Marrow Transplant Recipients 10/24/2012 10:37:09 AM
Enlivex Therapeutics Ltd. Completes Patient Enrollment in its Phase I/II Clinical Trial 1/23/2012 6:33:08 AM
Clinical Developments at Enlivex Therapeutics Ltd - a Hadasit Bio-Holdings Ltd.  (HDST) Portfolio Company 8/17/2011 11:00:06 AM
//-->